TPG Inc.-backed Asia OneHealthcare Sdn. has confidentially filed for an initial public offering in Kuala Lumpur, seeking to raise as much as 10 billion ringgit ($2.5 billion), according to people with knowledge of the matter.
The confidential filing is a preliminary step in Malaysia's IPO process, allowing the company to begin regulatory review before making its prospectus public. Confidential submissions have become standard practice globally as underwriters and issuers prepare documentation away from public view, compressing the timeline between announcement and listing.
Asia OneHealthcare operates healthcare facilities and services across Southeast Asia. TPG, the Philadelphia-based private equity firm with $147 billion in assets under management as of its latest quarterly filing, has invested in health services across multiple markets as part of its Asia-focused strategy. The company's healthcare portfolio has grown substantially over the past three years, with several exits and follow-on acquisitions in the region.
Malaysia's equity capital markets have seen varied IPO activity in recent years. The Kuala Lumpur stock exchange listed 71 companies in 2024, raising approximately 18.7 billion ringgit total, according to exchange data. Healthcare and biotech offerings have attracted institutional attention as demographic aging across Southeast Asia drives demand for medical services and facilities.
The size of the proposed offering would make it one of the largest IPOs from a private equity-backed healthcare operator in Malaysia, though it remains subject to regulatory approval and market conditions. Timing for a public listing has not been announced. The confidential filing process typically takes several months before a company moves to public submission of its prospectus.
TPG's exit through public markets in Kuala Lumpur would give the firm liquidity on the investment while retaining exposure to Asia's healthcare expansion. Healthcare valuations in Southeast Asia have remained resilient despite broader equity volatility, with public health services companies trading at median multiples between 12 and 16 times EBITDA.
The company to watch is whether Asia OneHealthcare moves from confidential filing to public prospectus submission within the next 12 months, which would indicate management and board confidence in market reception.
